Trials / Sponsors / AN2 Therapeutics, Inc
AN2 Therapeutics, Inc
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First-in-Human Trial of Oral AN2-502998 Healthy Volunteers | Phase 1 | 2025-08-04 |
| Completed | An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Meli Melioidosis | — | 2023-11-01 |
| Completed | A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2023-06-05 |
| Terminated | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease MAC Lung Disease, Treatment Refractory MAC Lung Disease | Phase 2 / Phase 3 | 2022-05-20 |
| Completed | A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function Renal Insufficiency | Phase 1 | 2022-02-21 |
| Completed | Phase 1 Study of Epetraborole Tablets Healthy Volunteers | Phase 1 | 2021-06-10 |